SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-19-002423
Filing Date
2019-02-13
Accepted
2019-02-13 14:55:45
Documents
2
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3830
2 poamcclellan.txt EX-24 3508
  Complete submission text file 0001225208-19-002423.txt   8673
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address THE BROOKINGS INSITUTION 1775 MASSACHUSETTS AVE., NW WASHINGTON DC 20036
Business Address
McClellan Mark B. (Reporting) CIK: 0001567006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 19596491